Sales of $482 million, up one percent from the prior-year quarter Income from continuing operations of $15 million, or $0.32 per diluted share Adjusted Income from Continuing Operations Excluding Intangibles...
WILMINGTON, Del., April 15, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its second-quarter fiscal 2026 earnings release at approximately 5 p.m. ET on Tuesday, April...
Wilmington, Del., March 23, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) is implementing pricing actions across its Life Sciences, Intermediates, Personal Care and Specialty Additives product portfolios...
WILMINGTON, Del., March 17, 2026 (GLOBE NEWSWIRE) -- William C. Whitaker, senior vice president and chief financial officer, Ashland (NYSE: ASH), will participate in a fireside chat at the Gabelli Funds’...
GREENWICH, Conn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Gabelli Funds will host its 17th Annual Specialty Chemicals Symposium in Midtown Manhattan, New York City on Thursday, March 19, 2026. The event will...
WILMINGTON, Del., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ashland announces the United States Environmental Protection Agency (EPA) has officially posted and approved its petition under the Federal Insecticide,...
Sales of $386 million, down five percent from the prior-year quarter Previously announced Avoca divestiture reduced overall sales by approximately $10 million or two percent versus the prior-year quarter;...
WILMINGTON, Del., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its first-quarter fiscal 2026 earnings release at approximately 5 p.m. ET on Monday, February...